Targeting miR-21 for the therapy of pancreatic cancer

208Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Despite tremendous efforts worldwide from clinicians and cancer scientists, pancreatic ductal adenocarcinoma (PDA) remains a deadly disease for which no cure is available. Recently, microRNAs (miRNAs) have emerged as key actors in carcinogenesis and we demonstrated that microRNA-21 (miR-21), oncomiR is expressed early during PDA. In the present study, we asked whether targeting miR-21 in human PDA-derived cell lines using lentiviral vectors (LVs) may impede tumor growth. We demonstrated that LVs-transduced human PDA efficiently downregulated miR-21 expression, both in vitro and in vivo. Consequently, cell proliferation was strongly inhibited and PDA-derived cell lines died by apoptosis through the mitochondrial pathway. In vivo, miR-21 depletion stopped the progression of a very aggressive model of PDA, to induce cell death by apoptosis; furthermore, combining miR-21 targeting and chemotherapeutic treatment provoked tumor regression. We demonstrate herein for the first time that targeting oncogenic miRNA strongly inhibit pancreatic cancer tumor growth both in vitro and in vivo. Because miR-21 is overexpressed in most human tumors; therapeutic delivery of miR-21 antagonists may still be beneficial for a large number of cancers for which no cure is available. © The American Society of Gene & Cell Therapy.

References Powered by Scopus

Global cancer statistics

31585Citations
N/AReaders
Get full text

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

6319Citations
N/AReaders
Get full text

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

3397Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Pancreatic ductal adenocarcinoma: Current and evolving therapies

434Citations
N/AReaders
Get full text

Exploring miRNA based approaches in cancer diagnostics and therapeutics

388Citations
N/AReaders
Get full text

The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics

330Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sicard, F., Gayral, M., Lulka, H., Buscail, L., & Cordelier, P. (2013). Targeting miR-21 for the therapy of pancreatic cancer. In Molecular Therapy (Vol. 21, pp. 986–994). Nature Publishing Group. https://doi.org/10.1038/mt.2013.35

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 53

70%

Researcher 17

22%

Lecturer / Post doc 4

5%

Professor / Associate Prof. 2

3%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 26

32%

Medicine and Dentistry 24

30%

Biochemistry, Genetics and Molecular Bi... 24

30%

Chemistry 7

9%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 27

Save time finding and organizing research with Mendeley

Sign up for free